3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
2
Pain
2
Visceral Pain
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Head and Neck Neoplasms
1
Bone Neoplasms
1
Agnosia
1
Interventions
Gemcitabine
3
Ethanol
3
fish oil triglycerides
2
S 1 (combination)
2
Metronidazole
2
Long-Term Synaptic Depression
2
Dexamethasone
2
pembrolizumab
1
pasireotide
1
nimotuzumab
1
ferumoxtran-10
1
alanylglutamine
1
Tobacco Use Cessation Devices
1
TachoSil
1
Sunitinib
1
Psychiatric Rehabilitation
1
Pregabalin
1
Polymerase Chain Reaction
1
Polygeline
1
Parenteral Nutrition
1
Pancrelipase
1
Oxaliplatin
1
Nutritional Status
1
Needles
1
Mirtazapine
1
Midazolam
1
Meperidine
1
Immunonutrition Diet
1
Hydrocortisone
1
Glucocorticoids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pancreatic Neoplasms
×
Pregabalin
×
Clear all
NCT01768988
2017-10-06
PANPAIN/1
Parc de Salut Mar
Phase 4
Terminated
20 enrolled